ADVIA Centaur HCV ReadyPack Reagents, Atellica IM Hepatitis C (aHCV), Atellica IM Hepatitis C Quality Control(aHCV QC)

FDA Premarket Approval P030056 S019

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

This supplement is for labeling changes as a result of biotin interference testing.

DeviceADVIA Centaur HCV ReadyPack Reagents, Atellica IM Hepatitis C (aHCV), Atellica IM Hepatitis C Quality Control(aHCV QC)
Generic NameAssay, Enzyme Linked Immunosorbent, Hepatitis C Virus
ApplicantSIEMENS HEALTHCARE DIAGNOSTICS
Date Received2020-12-22
Decision Date2021-03-11
PMAP030056
SupplementS019
Product CodeMZO 
Advisory CommitteeMicrobiology
Supplement TypeReal-time Process
Supplement ReasonLabeling Change - Indications/instructions/shelf Life/tradename
Expedited ReviewNo
Combination Product No
Applicant Address SIEMENS HEALTHCARE DIAGNOSTICS 333 Coney Street walpole, MA 02032-1516

Supplemental Filings

Supplement NumberDateSupplement Type
P030056Original Filing
S019 2020-12-22 Real-time Process
S018 2020-07-31 30-day Notice
S017 2020-05-22 30-day Notice
S016 2020-03-09 30-day Notice
S015 2020-02-21 30-day Notice
S014 2019-02-01 30-day Notice
S013 2018-07-19 Real-time Process
S012
S011 2017-09-29 Normal 180 Day Track
S010 2015-06-11 30-day Notice
S009 2015-05-01 Normal 180 Day Track
S008 2014-09-15 Normal 180 Day Track
S007 2012-03-26 Normal 180 Day Track No User Fee
S006 2009-05-18 Normal 180 Day Track
S005 2009-03-31 Normal 180 Day Track
S004 2009-03-09 Normal 180 Day Track No User Fee
S003 2009-02-04 30-day Notice
S002 2008-08-25 Normal 180 Day Track
S001

NIH GUDID Devices

Device IDPMASupp
00630414597867 P030056 002
00630414473161 P030056 002
00630414278759 P030056 002
00630414278742 P030056 002
00630414301341 P030056 002

© 2021 FDA.report
This site is not affiliated with or endorsed by the FDA.